T-Lymphocyte Regulated Tumor Cell Killing by Neutrophils - Richard Weisbart

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Research Project (R01)
Project #: 3R01CA030280-07S1
Application #: 3169192
Study Section: Experimental Immunology Study Section (EI)

Project Start: 1981-07-01
Project End: 1989-06-30
Budget Start: 1989-04-01
Budget End: 1989-06-30
Support Year: 7
Fiscal Year: 1989
Total Cost
Indirect Cost

Institution

Name: University of California Los Angeles
Department
Type: Schools of Medicine
DUNS #: 119132785

City: Los Angeles
State: CA
Country: United States
Zip Code: 90095

Related projects


NIH 1991 R01 CA	Molecular Events in Neutrophil Phagocytosis by Iga Weisbart, Richard / University of California Los Angeles
NIH 1990 R01 CA	Molecular Events in Neutrophil Phagocytosis by Iga Weisbart, Richard / University of California Los Angeles
NIH 1989 R01 CA	Molecular Events in Neutrophil Phagocytosis by Iga Weisbart, Richard / University of California Los Angeles
NIH 1989 R01 CA	T-Lymphocyte Regulated Tumor Cell Killing by Neutrophils Weisbart, Richard / University of California Los Angeles
NIH 1988 R01 CA	T-Lymphocyte Regulation of Neutrophils (PMN) Function Weisbart, Richard / University of California Los Angeles
NIH 1987 R01 CA	T-Lymphocyte Regulated Tumor Cell Killing by Neutrophils Weisbart, Richard / University of California Los Angeles
NIH 1986 R01 CA	T-Lymphocyte Regulated Tumor Cell Killing by Neutrophils Weisbart, Richard / University of California Los Angeles

Publications

Weisbart, R H (1992) An antibody that binds a neutrophil membrane protein, ERp72, primes human neutrophils for enhanced oxidative metabolism in response to formyl-methionyl-leucyl-phenylalanine. Implications for ERp72 in the signal transduction pathway for neutrophil priming. J Immunol 148:3958-63

Weisbart, R H; Golde, D W (1989) Physiology of granulocyte and macrophage colony-stimulating factors in host defense. Hematol Oncol Clin North Am 3:401-9

Mitsuyasu, R T; Golde, D W (1989) Clinical role of granulocyte-macrophage colony-stimulating factor. Hematol Oncol Clin North Am 3:411-25

Weisbart, R H; Kwan, L; Golde, D W et al. (1987) Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69:18-21

Gasson, J C; Kaufman, S E; Weisbart, R H et al. (1986) High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci U S A 83:669-73

Fleischmann, J; Golde, D W; Weisbart, R H et al. (1986) Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68:708-11

Weisbart, R H; Golde, D W; Gasson, J C (1986) Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol 137:3584-7

Weisbart, R H; Golde, D W; Clark, S C et al. (1985) Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 314:361-3

Comments

Be the first to comment on Richard Weisbart's grant